TY - JOUR
T1 - Loss-of-Function Mutation in the Dioxygenase-Encoding FTO Gene Causes Severe Growth Retardation and Multiple Malformations
AU - Boissel, Sarah
AU - Reish, Orit
AU - Proulx, Karine
AU - Kawagoe-Takaki, Hiroko
AU - Sedgwick, Barbara
AU - Yeo, Giles S.H.
AU - Meyre, David
AU - Golzio, Christelle
AU - Molinari, Florence
AU - Kadhom, Noman
AU - Etchevers, Heather C.
AU - Saudek, Vladimir
AU - Farooqi, I. Sadaf
AU - Froguel, Philippe
AU - Lindahl, Tomas
AU - O'Rahilly, Stephen
AU - Munnich, Arnold
AU - Colleaux, Laurence
N1 - Funding Information:
We are grateful to the patients for their participation in the study. We acknowledge Jean Philippe Jais for LOD score calculation, Carron Sher for participation to clinical evaluation, Uli Rüther for kindly providing FTO antibodies, Céline Cluzeau for help with western blotting, Peter Robins for purification of FTO protein, and Marcella Ma and Debbie Lyon for additional technical assistance. This study was supported by the Centre National de la Recherche Scientifique, the Agence Nationale de la Recherche, the Région Ile-de-France, EU FP6 EUGENE2 (LSHM-CT-2004-512013), EC FP6 Marie Curie, the Medical Research Council UK, Cancer Research UK, the Wellcome Trust, and NIHR Cambridge Biomedical Research Centre.
PY - 2009/7/10
Y1 - 2009/7/10
N2 - FTO is a nuclear protein belonging to the AlkB-related non-haem iron- and 2-oxoglutarate-dependent dioxygenase family. Although polymorphisms within the first intron of the FTO gene have been associated with obesity, the physiological role of FTO remains unknown. Here we show that a R316Q mutation, inactivating FTO enzymatic activity, is responsible for an autosomal-recessive lethal syndrome. Cultured skin fibroblasts from affected subjects showed impaired proliferation and accelerated senescence. These findings indicate that FTO is essential for normal development of the central nervous and cardiovascular systems in human and establish that a mutation in a human member of the AlkB-related dioxygenase family results in a severe polymalformation syndrome.
AB - FTO is a nuclear protein belonging to the AlkB-related non-haem iron- and 2-oxoglutarate-dependent dioxygenase family. Although polymorphisms within the first intron of the FTO gene have been associated with obesity, the physiological role of FTO remains unknown. Here we show that a R316Q mutation, inactivating FTO enzymatic activity, is responsible for an autosomal-recessive lethal syndrome. Cultured skin fibroblasts from affected subjects showed impaired proliferation and accelerated senescence. These findings indicate that FTO is essential for normal development of the central nervous and cardiovascular systems in human and establish that a mutation in a human member of the AlkB-related dioxygenase family results in a severe polymalformation syndrome.
UR - http://www.scopus.com/inward/record.url?scp=67649875640&partnerID=8YFLogxK
U2 - 10.1016/j.ajhg.2009.06.002
DO - 10.1016/j.ajhg.2009.06.002
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 19559399
AN - SCOPUS:67649875640
VL - 85
SP - 106
EP - 111
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
SN - 0002-9297
IS - 1
ER -